← Eichor
Study identifier: NCT05637294 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome

Condition: Carpal Tunnel Syndrome  ·  Sponsor: Tampere University Hospital

PhaseNA
Planned participants110
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Carpal tunnel syndrome is a common compression neuropathy of upper extremities. Its usual symptoms are pain, numbness and tingling of fingers, which tend to be worse at night. Splinting the wrist with an external orthosis is usually a first-line treatment provided to most people with mild to moderate disease. The FINCROSS trial (randomized cross-over trial) aims to assess the effect of night-time and full-time splinting in comparison with no-treatment. It also aims to identify possible subgroups of people who would benefit from splinting, as well as assess if positive response to splinting is associated with subsequent lower need of surgery. The trial will recruit 110 people with carpal tunnel syndrome in Finland. Each participant will undergo all three treatment periods in a randomised order: 1) splinting at night-time for six weeks, 2) splinting both day and night for six weeks; and 3) be assessed under a six weeks long control period of no-treatment. Each treatment period will be separated with a three-week washout period. Therefore, the whole treatment sequence for each participant lasts 24 weeks after randomization. The participant will be followed-up to 1 year after the randomisation. Additionally, the participants will get instructions for self-administered stretching exercises to perform throughout the study. All participants will be asked to avoid any intervention administered or supervised by medical personnel (such as structured supervised exercises, manual the…

This description comes directly from the study's public registry record.

Talk to the study team

Vieda Lusa  ·  +358408713465  ·  fincross.trial@gmail.com

Always discuss trial participation with your own doctor first.

Locations (6)

Terveystalo KamppiHelsinki, FinlandRecruiting
Hospital Nova of Central FinlandJyväskylä, FinlandRecruiting
Terveystalo JyväskyläJyväskylä, FinlandRecruiting
Mikkeli Central HospitalMikkeli, FinlandRecruiting
Tampere University HospitalTampere, FinlandActive Not Recruiting
Terveystalo TampereTampere, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05637294